L. Lochman et al. / Dyes and Pigments 121 (2015) 178e187
181
partially evaporated under reduced pressure. The product was
2.3.3. Compound 1 dH
poured into a solution of water/MeOH/acetic acid 10:5:1 (v/v) and
stirred for 45 min at rt. The dark green solid was collected by
filtration, subsequently washed several times with water and dried.
The product was dissolved in THF, p-toluenesulfonic acid (10 equiv.)
was added and the solution was stirred for 2 h at rt, protected from
light by an aluminum cover. The solution was concentrated under
reduced pressure, then diluted with water. The precipitate was
collected, and thoroughly washed with water. The unsymmetrical
congener (AAAB type) was isolated and purified by repeated col-
umn chromatography on silica. After the symmetrical congener
(type AAAA) was washed out, the mobile phase was changed to a
mobile phase with a higher Rf of product. The mobile phases and
number of repetitions are given for each compound below. The
metal free 1aH,1 cH or 1 dH was suspended in MeOH (1aH, 1 cH) or
hexane (compound 1 dH), collected, washed with either MeOH or
hexane and thoroughly dried under reduced pressure.
Starting amount: Mg (186 mg, 7.65 mmol), 3d (139 mg,
0.27 mmol), 7 (252 mg, 0.82 mmol), reaction time 5 h; p-toluene-
sulfonic acid (432 mg, 2.27 mmol); eluent: chloroform/toluene/THF
5:10:1, mobile phase was changed to chloroform/THF 5:1
(Rf ¼ 0.37) (twice); yield: 39 mg (10%) of the dark green solid; 1H
NMR (300 MHz, CDCl3/pyridine-d5, 25 ꢂC):
d
¼ ꢀ2.54 (br s, 2 H, NH),
1.24-1.39 (m,
3
H, OCH2CH2CH2CH3), 1.80-1.93 (m, H,
4
OCH2CH2CH2CH3), 2.16 (s, 9 H, CCH3), 2.18 (s, 9 H, CCH3), 2.23 (s, 18
H, CCH3), 2.25 (s, 18 H, CCH3), 3.76-3.95 (m, 20 H, crown-H), 4.22-
4.38 (m, 4 H, crown-H), 4.42-4.63 (m, 4 H, crown-H, overlapped
with signal of water) and 5.18 ppm (t,
J
¼
7 Hz, 2H,
OCH2CH2CH2CH3); 13C NMR (75 MHz, CDCl3/pyridine-d5, 25 ꢂC):
d
¼ 14.3, 19.9, 30.65, 30.85, 30.93, 31.1, 51.2, 51.9, 52.7, 68.2, 70.74,
70.82, 70.99, 71.1, 71.3, 127.8, 133.8, 139.7, 140.7, 143.0, 143.4, 143.79,
143.81, 144.27, 144.31, 144.7, 144.8, 145.0, 145.3, 152.2. 157.3, 158.1,
158.5, 160.1 and 160.2 ppm; IR (ATR): 3306, 2957, 2868, 2580, 1726,
1639, 1513, 1477, 1362, 1280, 1248, 1139, 1077, 1028 and 969 cm-1
;
UV/Vis (ACN): lmax (ε) ¼ 672 (42 520), 649 (41 690), 622 sh, 591 sh,
539 sh, 470 (19 560), 363 (58 690 mol-1dm3cmꢀ1); UV/Vis (THF):
lmax (ε) ¼ 672 (54 720), 650 (48 300), 620 sh, 595 sh, 522 sh, 473
(22 720), 366 (63 200 mol-1dm3cmꢀ1); HR MS (ESIþ): calcd for
2.3.1. Compound 1aH
Starting amount: Mg (1.09 g, 44.75 mmol), 3a (600 mg,
1.60 mmol), 7 (1.47 g, 4.80 mmol), reaction time 6 h; p-toluene-
sulfonic acid (3.00 g,15.77 mmol); eluent: toluene/THF 50:1, mobile
phase was changed to toluene/THF 10:1 (Rf ¼ 0.64) (twice); yield:
305 mg (15%) of the dark green solid; 1H NMR (300 MHz, CDCl3/
C
66H93N17O7S6 m/z ¼ 1428.5846 [MþH]þ; found m/z ¼ 1428.5830
[MþH]þ; MS (MALDI-TOF): m/z ¼ 1427.5 [M]þ; 1450.5 [MþNa]þ;
1466.5 [MþK]þ.
pyridine-d5, 25 ꢂC):
d
¼ 1.25e1.38 (m, 5H, OCH2CH2CH2CH3),
1.81e1.91 (m, 2 H, OCH2CH2CH2CH3), 2.16 (s, 18 H, CCH3), 2.22 (s, 18
H, CCH3), 2.25 (s, 18 H, CCH3), 3.75e3.90 (m, 8 H, crown-H),
4.33e4.42 (m, 4 H, crown-H), 4.47e4.56 (m, 4 H, crown-H) and
5.15 ppm (t, J ¼ 7 Hz, 2 H, OCH2CH2CH2CH3); 13C NMR (75 MHz,
2.4. General procedure for the synthesis of magnesium AzaPcs
Metal free AzaPc 1aH, 1 cH or 1 dH (1 equiv.) was dissolved in
pyridine and anhydrous magnesium acetate (1 equiv.) was added.
The mixture was refluxed for 1.5 h. The reaction mixture was cooled
down and water was added. The precipitate was collected and
washed with water several times, followed by water/MeOH 1:1 (v/
v). The product was purified by column chromatography on silica
(mobile phases are given for each compound below). The product
was suspended in MeOH (1aMg, 1cMg) or hexane (compound
1dMg), and the solid was collected and thoroughly dried under
reduced pressure.
CDCl3/pyridine-d5, 25 ꢂC):
d
¼ 14.2, 19.8, 29.8, 30.7, 30.87, 30.95,
31.0, 51.19, 51.24, 51.28, 51.80, 51.85, 53.3, 68.0, 70.4, 71.4, 133.8,
139.5, 139.6, 144.0, 144.4, 144.8, 145.2, 149.0, 152.3, 157.19, 157.21,
157.9, 158.3, 159.95 and 160.05 ppm; IR (ATR): 3304, 2957, 2929,
2862, 1509, 1477, 1362, 1281, 1234, 1139, 1102, 1076 and 969 cm-1
;
UV/Vis (ACN): lmax (ε) ¼ 671 (85 710), 649 (79 960), 532 (35 020),
470 (43 370), 364 (125 370 mol-1dm3cmꢀ1); UV/Vis (THF): lmax
(ε) ¼ 671 (112 470), 648 (97 450), 619 sh, 593 sh, 521 sh, 476
(46 680), 366 (127 690 mol-1dm3cmꢀ1); HR MS (ESIþ): calcd for
C
60H81N17O4S6 m/z ¼ 1296.5060 [MþH]þ; found m/z ¼ 1296.5062
2.4.1. Compound 1aMg
[MþH]þ; MS (MALDI-TOF): m/z ¼ 1295.4 [M]þ; 2590.7 [2M]þ.
Starting amount: 1aH (40 mg, 0.031 mmol), Mg(CH3COO)2
(4.4 mg, 0.031 mmol); eluent: toluene/THF 10:1 (Rf ¼ 0.07), mobile
phase was changed to toluene/THF 2:1; yield: 31 mg (76%) of green
2.3.2. Compound 1 cH
Starting amount: Mg (735 mg, 30.23 mmol), 3c (500 mg,
1.08 mmol), 7 (992 mg, 3.24 mmol), reaction time 5 h; p-toluene-
sulfonic acid (543 mg, 2.85 mmol); eluent: toluene/THF 30:1, mo-
bile phase was changed to chloroform/THF 30:1 (Rf ¼ 0.07) (twice);
yield: 130 mg (9%) of the dark green solid; 1H NMR (300 MHz,
solid; 1H NMR (300 MHz, CDCl3/pyridine-d5, 25 ꢂC):
d
¼ 1.24 (t,
J
¼
7
Hz, 3H, OCH2CH2CH2CH3), 1.71e1.88 (m, 4H,
OCH2CH2CH2CH3), 2.20 (s, 9 H, CCH3), 2.21 (s, 9 H, CCH3), 2.24 (s, 36
H, CCH3), 3.79e3.90 (m, 8 H, crown-H), 4.41e4.51 (m, 8 H, crown-
H) and 5.13 ppm (t, J ¼ 6 Hz, 2H, OCH2CH2CH2CH3); 13C NMR
CDCl3/pyridine-d5, 25 ꢂC):
d
¼ ꢀ2.86 (br s, 2 H, NH), 1.32 (t, J ¼ 7 Hz,
(75 MHz, CDCl3/pyridine-d5, 25 ꢂC):
d
¼ 14.1, 19.8, 30.9, 31.0, 31.1,
3 H, OCH2CH2CH2CH3), 1.82-1.97 (m, 4 H, OCH2CH2CH2CH3), 2.17 (s,
18 H, CCH3), 2.23 (s, 18 H, CCH3), 2.26 (s, 18 H, CCH3), 3.83-3.93 (m,
16 H, crown-H), 4.27-4.35 (m, 4 H, crown-H), 4.50-4.60 (m, 4 H,
crown-H) and 5.18 (t, J ¼ 7 Hz, 2 H, OCH2CH2CH2CH3); 13C NMR
51.2, 51.31, 51.33, 53.2, 67.7, 70.3, 71.6, 71.7, 78.0, 138.5, 144.5, 144.7,
144.8, 144.9, 145.0, 145.3, 148.7, 150.1, 150.3, 150.4, 151.0, 151.2,
152.2,152.4,157.3,157.5,157.8,157.9,158.4 and 158.8 ppm; IR (ATR):
2958, 2901, 1573, 1521, 1461, 1362, 1251, 1144, 1093 and 975 cm-1
;
(75 MHz, CDCl3/pyridine-d5, 25 ꢂC):
d
¼ 14.3, 19.9, 30.7, 30.9, 31.0,
UV/Vis (ACN): lmax (ε) ¼ 656 (196 720), 598 (35 470), 375
(158 870 mol-1dm3cmꢀ1); UV/Vis (THF): lmax (ε) ¼ 655 (223 760),
596 (39 430), 462 sh, 382 (178 740 mol-1dm3cmꢀ1); HR MS (ESIþ):
calcd for C60H79MgN17O4S6 m/z ¼ 1318.4754 [MþH]þ; found m/
z ¼ 1318.4740 [MþH]þ; MS (MALDI-TOF): m/z ¼ 1317.4 [M]þ;
1340.4 [MþNa]þ; 1356.4 [MþK]þ.
31.2, 51.23, 51.27, 51.84, 52.7, 68.1, 70.1, 71.0, 71.1, 133.8, 139.6, 140.5,
144.5, 144.7, 144.8, 145.1, 152.2,157.16, 157.22,157.9, 158.3, 160.0 and
160.10 ppm; IR (ATR): 2961, 2864,1519,1478,1425,1362,1313,1279,
1247, 1138, 1076, 1025 and 967 cm-1; UV/Vis (ACN): lmax (ε) ¼ 670
(54 810), 650 (52 910), 618 sh, 597 sh, 531 (20 830), 476 (27 220),
362 (83 110 mol-1dm3cmꢀ1); UV/Vis (THF): lmax (ε) ¼ 672 (74 010),
649 (67 060), 619 sh, 596 sh, 522 sh, 473 (28 980), 365 (91 880 mol-
1dm3cmꢀ1); HR MS (ESIþ): calcd for C64H89N17O6S6 m/
z ¼ 1384.5584 [MþH]þ; found m/z ¼ 1384.5582 [MþH]þ; MS
(MALDI-TOF): m/z ¼ 1383.4 [M]þ; 1406.4 [MþNa]þ; 2766.8 [2M]þ;
2789.8 [2M þ Na]þ.
2.4.2. Compound 1cMg
Starting amount: 1 cH (13.4 mg, 0.0097 mmol), Mg(CH3COO)2
(1.4 mg, 0.0097 mmol); eluent: chloroform/THF 6:1 (Rf ¼ 0.03),
mobile phase was changed to chloroform/THF 4:1 (Rf ¼ 0.06); yield:
12.8 mg (94%) of green solid; 1H NMR (300 MHz, CDCl3/pyridine-d5,